Peter Rieckmann received his medical degree from the University of Göttingen, Germany in 1988. After a postdoctoral fellowship in molecular immunology at the NIH, Bethesda, USA he completed his training in Neurology at the National Institute for Nervous Disease, London, UK and the University of Göttingen, Germany. Prof. Rieckmann received German Board certification in Neurology in 1995. His academic and clinical positions have included Senior (staff) Neurologist and Professor for Neurology, Dept. of Neurology, as well as head of the Clinical Research Group for Multiple Sclerosis and Neuroimmunology, at the Julius-Maximilians University of Würzburg.
In 2007 Prof. Rieckmann became the Multiple Sclerosis Society of Canada Research Chair and Director of the MS Program and Full Tenured Professor at the University of British Columbia, Vancouver, Canada. Under his leadership the Vancouver MS clinical research program was awarded Western-Pacific Research and Training Center by the MS Society of Canada. He is a founding member of the EndMS campaign in Canada and was instrumental in establishing the Center for Brain Health at UBC in Vancouver (http://www.centreforbrainhealth.ca).
In September 2009 he started a new position as the Chair of the Department of Neurology at the Academic Hospital in Bamberg, and as a Professor of Neurology at the University of Erlangen, Germany. Since 2012, he also serves as deputy medical director of the Academic Hospital in Bamberg. In the same year, he started the MS in the 21st century steering group, a think tank of international experts and people with MS working on innovative principles of MS care and patient engagement.
Together with colleagues from cardiology, psychiatry, neurosurgery, vascular medicine and neuroradiology he raised funds for Germany’s first Heart and Brain Center, which started its operation in December 2016 at Bamberg Academic Hospital. He was also the first acting Director of this innovative, interdisciplinary center.
Recently, Prof. Rieckmann became the Medical Director and the Head of the Hospital for Nervous diseases at the Medical Park Loipl/Bavaria to establish in cooperation with the Paracelsus Medical University in Salzburg (Austria) innovative concepts of neurorehabilitation.
His major research interests are disease modifying factors and repair mechanisms in multiple sclerosis and stroke as well as improvement of rehabilitation strategies to facilitate plasticity and functional restoration. His clinical goals include enhancing awareness and education about MS and stroke, developing effective and properly resourced services for care (including digital remote monitoring), and providing more customized treatments.
As a clinician scientist he is actively involved in different efforts to transfer bench results to clinical developments and serves on steering committees and advisory boards of various investigator-initiated MS trials and international multi-centre studies (Phase II and III).
Prof. Rieckmann is also a Fellow of the Royal College of Physicians and Surgeons Canada (FRCPC), Fellow of the American Academy of Neurology (FAAN) and holds several positions as visiting professor across the globe. He has received numerous awards - including Gerhard Hess prize of the German Research Association (DFG) - and research grants with over 250 papers to his credit in peer-reviewed medical journals.